CoChat

Leveraging microenvironmental synthetic lethalities to treat cancer

Open access
Metcalf, Kevin J., Alazzeh, Alaa, Werb, Zena, Weaver, Valerie M. · 2021 · Journal of Clinical Investigation

The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.

Abstract

Treatment resistance leads to cancer patient mortality. Therapeutic approaches that employ synthetic lethality to target mutational vulnerabilities in key tumor cell signaling pathways have proven effective in overcoming therapeutic resistance in some cancers. Yet, tumors are organs composed of malignant cells residing within a cellular and noncellular stroma. Tumor evolution and resistance to anticancer treatment are mediated through a dynamic and reciprocal dialogue with the tumor microenvironment (TME). Accordingly, expanding tumor cell synthetic lethality to encompass contextual synthetic lethality has the potential to eradicate tumors by targeting critical TME circuits that promote tumor progression and therapeutic resistance. In this Review, we summarize current knowledge about the TME and discuss its role in treatment. We outline the concept of tumor cell-specific synthetic lethality and describe therapeutic approaches to expand this paradigm to leverage TME synthetic lethality to improve cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci143765

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 145 references

Cited by

See all 42

Metadata

Authors
Metcalf, K. J., Alazzeh, A., Werb, Z., & Weaver, V. M.
Affiliations
  • UCSF Helen Diller Family Comprehensive Cancer Center (US)
  • University of California, San Francisco (US)
Corresponding author
Weaver, Valerie M.
Venue
Journal of Clinical Investigation
Published
2021-03-15
Volume
131
Issue
6
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3136876771
Cited by
42
References
145
Citations by year
2026: 9 · 2025: 6 · 2024: 10 · 2023: 5 · 2022: 8 · 2021: 4
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (R35CA242447, R01CA227942)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
synthetic lethality, tumor microenvironment, treatment resistance, cancer therapy, tumor stroma, tumor evolution
MeSH terms
Synthetic Lethal Mutations, Animals, Female, Humans, Immunotherapy, Male, Neoplasms, Signal Transduction, Disease Progression, Drug Resistance, Neoplasm, Molecular Targeted Therapy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leveraging microenvironmental synthetic lethalities to treat cancer. https://app.cochat.ai/papers/10.1172/jci143765
The paper
Metcalf, K. J., Alazzeh, A., Werb, Z., & Weaver, V. M. (2021). Leveraging microenvironmental synthetic lethalities to treat cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci143765

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.